|
|
核医学技术对乳腺癌骨转移诊断的价值分析
|
Abstract:
乳腺癌骨转移是导致乳腺癌患者死亡的主要原因之一。核医学技术具有全身性评估、高灵敏度和特异性等优势，能够提供准确的骨转移信息。全身骨显像、正电子发射断层显像(PET)和单光子发射计算机断层成像(SPECT)是诊断骨转移瘤的常用检查方法，各有优劣势。核医学技术在乳腺癌骨转移的评价中具有独特的优势，综合使用这些技术可以提供准确的骨转移评估和全身性疾病分期，为乳腺癌患者的治疗决策和预后评估提供重要依据。本文旨在分析核医学技术在乳腺癌骨转移评价中的应用和优势，为患者提供更精准的诊断和治疗策略。
Bone metastasis from breast cancer is one of the leading causes of mortality in breast cancer patients. Nuclear medicine techniques offer advantages such as whole-body assessment, high sensitivity, and specificity, allowing for accurate detection of bone metastasis. Whole-body bone scintigraphy, PET, and SPECT imaging are commonly used methods for diagnosing bone metastatic lesions, each with its own advantages and limitations. Nuclear medicine techniques have unique advantages in the evaluation of bone metastasis from breast cancer, and the combined use of these techniques can provide accurate assessment of bone metastasis and systemic disease staging, offering crucial information for treatment decisions and prognostic evaluation in breast cancer patients. This article aims to analyze the application and advantages of nuclear medicine techniques in the evaluation of bone metastasis from breast cancer, providing patients with more precise diagnosis and treatment strategies.
| [1] | Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. https://doi.org/10.3322/caac.21834 |
| [2] | Muzi, M., Peterson, L.M., Specht, J.M., Hippe, D.S., Novakova-Jiresova, A., Lee, J.H., et al. (2024) Repeatability of 18F-FDG Uptake in Metastatic Bone Lesions of Breast Cancer Patients and Implications for Accrual to Clinical Trials. EJNMMI Research, 14, Article No. 32. https://doi.org/10.1186/s13550-024-01093-7 |
| [3] | Coleman, R.E. (2006) Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity. Clinical Cancer Research, 12, 6243s-6249s. https://doi.org/10.1158/1078-0432.ccr-06-0931 |
| [4] | 王如良, 张少华. 乳腺癌骨转移和骨相关疾病临床诊疗研究进展[J]. 中国医药, 2022, 17(7): 1111-1115. |
| [5] | 刘沫含, 周星彤, 孙强. 乳腺癌骨转移研究进展——从基础到临床[J]. 协和医学杂志, 2023, 14(3): 638-645. |
| [6] | 李娜, 屈辉. 骨转移瘤的影像学诊断进展[J]. 中国医学影像技术, 2006(1): 159-162. |
| [7] | 陈凤, 崔亚利. 骨转移瘤影像学检查研究概述[J]. 医学综述, 2019, 25(1): 134-138+143. |
| [8] | 陈丽媚. 全身骨显像联合单光子发射计算机断层扫描/计算机断层扫描融合显像诊断乳腺癌骨转移的临床应用价值分析[J]. 大医生, 2023, 8(23): 112-114. |
| [9] | Wu, Q., Yang, R., Zhou, F. and Hu, Y. (2013) Comparison of Whole-Body MRI and Skeletal Scintigraphy for Detection of Bone Metastatic Tumors: A Meta-Analysis. Surgical Oncology, 22, 261-266. https://doi.org/10.1016/j.suronc.2013.10.004 |
| [10] | Iagaru, A. and Minamimoto, R. (2018) Nuclear Medicine Imaging Techniques for Detection of Skeletal Metastases in Breast Cancer. PET Clinics, 13, 383-393. https://doi.org/10.1016/j.cpet.2018.02.002 |
| [11] | Hamaoka, T., Madewell, J.E., Podoloff, D.A., Hortobagyi, G.N. and Ueno, N.T. (2004) Bone Imaging in Metastatic Breast Cancer. Journal of Clinical Oncology, 22, 2942-2953. https://doi.org/10.1200/jco.2004.08.181 |
| [12] | 余学军, 李玲玲. 全身骨显像和单光子发射计算机断层显像/CT局部断层融合显像在肺癌骨转移诊断中的应用[J]. 实用医学影像杂志, 2023, 24(6): 452-454. |
| [13] | Janicek, M. and Shaffer, K. (1995) Scintigraphic and Radiographic Patterns of Skeletal Metastases in Breast Cancer: Value of Sequential Imaging in Predicting Outcome. Skeletal Radiology, 24, 597-600. https://doi.org/10.1007/bf00204859 |
| [14] | 饶良俊, 王晓燕, 陈志丰, 罗炳棋, 张祥松, 史新冲, 易畅. 对比分析~(99m)Tc-MDP SPECT与~(18)F-NaF PET/CT术前诊断肺癌骨转移的价值[J]. 中国医学影像技术, 2012, 28(12): 2233-2238. |
| [15] | 朱焓钰, 黄晓红, 石野宽, 游金辉. ~(18)F-NaF PET/CT在骨骼疾病诊断中的应用与研究进展[J]. 安徽医学, 2024, 45(3): 376-379. |
| [16] | Ahmed, N., Sadeq, A., Marafi, F., Gnanasegaran, G. and Usmani, S. (2022) Therapy-Induced Bone Changes in Oncology Imaging with 18F-Sodium Fluoride (NaF) PET-CT. Annals of Nuclear Medicine, 36, 329-339. https://doi.org/10.1007/s12149-022-01730-y |
| [17] | Refaat, R., Abd Alkhalik Basha, M., Sobhi Hassan, M., Hussein, R.S., Al-Molla, R.M., Awad, N.M., et al. (2019) Is FDG Maximum Standardized Uptake Value of Primary Breast Cancer a Prognostic Factor for Locoregional Axillary Lymph Node Metastasis? Acta Radiologica, 60, 1241-1250. https://doi.org/10.1177/0284185118824770 |
| [18] | 王禾, 张亚男. PET及PET/CT在乳腺癌骨转移早期诊断中应用的研究进展[J]. 东南大学学报(医学版), 2021, 40(1): 129-132. |
| [19] | 石庆学, 许欣茹, 郭佳, 左峰, 张宗鹏, 张国旭, 王治国. ~(18)F-NaF PET/CT显像与~(99m)Tc-MDP SPECT骨显像对乳腺癌患者骨转移诊断的对比研究[J]. 中国临床医学影像杂志, 2021, 32(1): 40-43. |
| [20] | 何婷婷, 施彦坤, 苑克慧, 黄江山, 李哲成, 胡蓉蓉, 李群, 王卉. ~(18)F-氟化钠PET-CT显像中低剂量CT在骨转移病变中的诊断价值[J]. 中国医学装备, 2017, 14(7): 76-79. |
| [21] | Eubank, W.B., Lee, J.H. and Mankoff, D.A. (2009) Disease Restaging and Diagnosis of Recurrent and Metastatic Disease Following Primary Therapy with FDG-PET Imaging. PET Clinics, 4, 299-312. https://doi.org/10.1016/j.cpet.2009.09.001 |
| [22] | 罗焱文, 朱庆莉. 乳腺癌影像组学研究进展[J]. 协和医学杂志, 2021, 12(6): 983-988. |
| [23] | 许阿磊. 精准定量SPECT/CT在乳腺癌骨转移诊断和疗效评估方面的应用[D]: [硕士学位论文]. 合肥: 安徽医科大学, 2020. |
| [24] | Fan, Z., Wang, T., Zou, L. and Liu, D. (2023) Comparison of the Diagnostic Value of 18F-NaF PET/CT and 99mTc-MDP SPECT for Bone Metastases: A Systematic Review and Meta-Analysis. Translational Cancer Research, 12, 3166-3178. https://doi.org/10.21037/tcr-23-817 |
| [25] | Ikeda, T., Kitajima, K., Tsuchitani, T., et al. (2022) Effectiveness of Quantitative Bone SPECT/CT for Bone Metastasis Diagnosis. Hellenic Journal of Nuclear Medicine, 25, 253-259. |
| [26] | 宋宏涛, 罗诗雨, 王磊. SPECT/CT在骨显像骨外放射性分布异常诊断中的增益价值[J]. 标记免疫分析与临床, 2023, 30(6): 927-931+941. |
| [27] | Sharma, P., Singh, H., Kumar, R., Bal, C., Thulkar, S., Seenu, V., et al. (2012) Bone Scintigraphy in Breast Cancer: Added Value of Hybrid SPECT-CT and Its Impact on Patient Management. Nuclear Medicine Communications, 33, 139-147. https://doi.org/10.1097/mnm.0b013e32834e3b14 |
| [28] | 王东, 孟宪平, 陈则君, 靳激扬. SPECT/CT融合图像与全身骨显像对骨转移瘤诊断的价值分析[J]. 中国CT和MRI杂志, 2016, 14(4): 126-129. |
| [29] | 刘洁. SPECT/CT融合显像在肿瘤骨转移诊断中的增益价值[D]: [硕士学位论文]. 上海: 上海交通大学, 2016. |
| [30] | Chakraborty, S., Chatterjee, S., Chakravarty, R., Sarma, H.D., Nanabala, R., Goswami, D., et al. (2024) Synthesis, Quality Control, and Bench-to-Bed Translation of a New [68Ga]Ga-Labeled Nota-Conjugated Bisphosphonate for Imaging Skeletal Metastases by Positron Emission Tomography. Cancer Biotherapy and Radiopharmaceuticals, 39, 92-101. https://doi.org/10.1089/cbr.2023.0077 |
